Cronos Group Inc. (TSX:CRON)
Market Cap | 1.03B |
Revenue (ttm) | 169.23M |
Net Income (ttm) | 59.11M |
Shares Out | 382.53M |
EPS (ttm) | 0.15 |
PE Ratio | 17.45 |
Forward PE | 256.17 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 183,551 |
Average Volume | 598,872 |
Open | 2.680 |
Previous Close | 2.700 |
Day's Range | 2.590 - 2.680 |
52-Week Range | 2.550 - 4.280 |
Beta | 0.94 |
RSI | 40.03 |
Earnings Date | Feb 28, 2025 |
About Cronos Group
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. The company offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. Cronos Group Inc. was founded in 2012 and is based in Stayner, Canada. [Read more]
News
Marijuana Stock Movers For March 24, 2025
GAINERS: Affinor Growers (OTC: RSSFF) shares closed up 19.75% at $0.05 Blueberries Medical (OTC: BBRRF) shares closed up 16.25% at $0.01 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 11.98% at ...

Cronos Stock: Win Big Or Lose All
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash b...

3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U....

Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna ...
Cronos Group Inc. (CRON) 37th Annual Roth Conference (Transcript)

Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Ch...

Cronos Reports Improved Q4-2024 Financials With Revenues From GrowCo
Cronos reported 27% increase in revenues YOY for Q4-2024. The company is now reporting revenues from its 50% ownership of GrowCo. The company reported increasing profits and free cash flow for the qua...

Top Marijuana Stocks To Know In Today's Stock Market 2025
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader c...

Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc (NASDAQ: CRON) reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million . The increase year-over-year was primaril...

Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc CRON reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million.

Cronos Group (CRON) Q4 2024 Earnings Call Transcript
CRON earnings call for the period ending December 31, 2024.
Cronos Group Inc. (CRON) Q4 2024 Earnings Call Transcript

Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
Stocks in the cannabis sector notched notable gains on Thursday, according to Benzinga Pro data, with Cronos Group (NASDAQ: CRON) up 3.82%, Verano Holdings (OTC: VRNOF) up 1.11%, Trulieve (OTC: TCNN...
Cronos Group Inc (CRON) Q4 2024 Earnings: Revenue at $30. ...
Cronos Group Inc (CRON) Q4 2024 Earnings: Revenue at $30.3M Misses Estimates, Net Income Reaches $43.9M
Cronos Group GAAP EPS of $0.11 beats by $0.12, revenue of $30.3M misses by $4.54M

Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million

Earnings Scheduled For February 27, 2025
Companies Reporting Before The Bell • Hafnia (NYSE: HAFN) is estimated to report earnings for its fourth quarter. • argenx (NASDAQ: ARGX) is projected to report quarterly earnings at $1.06 per share...
Cronos Group Q4 Earnings Preview

Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday...

3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise
The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no f...

Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.

Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are p...

Top Canadian Marijuana Stocks For Your 2025 Watchlist
Most marijuana stock investors are excited about the upcoming trading year. 2025 has lots of potential in various fashions that are keeping hopes high for investors and legal operators. To start there...

Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.

2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by ...